Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation

The recent surge in therapeutic mRNA for vaccination has provided a blueprint for the design of the mRNA molecule, as several complex structural elements indicated as 5′ and 3′ untranslated regions (UTRs) and poly-A tail have been identified as necessary for in vitro transcribed mRNA stability and r...

Full description

Saved in:
Bibliographic Details
Main Authors: Arthur Esprit, Dorien Autaers, Ilke Aernout, Ine Lentacker, Steve Pascolo, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253125001453
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The recent surge in therapeutic mRNA for vaccination has provided a blueprint for the design of the mRNA molecule, as several complex structural elements indicated as 5′ and 3′ untranslated regions (UTRs) and poly-A tail have been identified as necessary for in vitro transcribed mRNA stability and reduced immunogenicity. In this work, we investigated the contribution of each structural component on protein expression of antigen-encoding mRNA, in vitro and ex vivo, delivered via electroporation in antigen-presenting cells. After initial investigation, showcasing the effect of sequence, or chemical, modifications on mRNA translation and protein expression, we validated the effect of a structural deconstruction on antigen coding mRNA, observing preserved antigen presentation upon removal of stabilizing structures like the 5′ and 3′ UTRs and poly-A tail. Moreover, we implemented these findings and established a straightforward method for generating synthetic DNA templates for in vitro transcription, resulting in accelerated mRNA production, facilitating high-throughput screening and evaluation of antigen immunogenicity.
ISSN:2162-2531